IT1249060B - Composizione farmaceutica ad uso topico per il trattamento di cicatrizzazione e riepitelizzazione di ulcere flebostatiche croniche. - Google Patents

Composizione farmaceutica ad uso topico per il trattamento di cicatrizzazione e riepitelizzazione di ulcere flebostatiche croniche.

Info

Publication number
IT1249060B
IT1249060B ITMI911439A ITMI911439A IT1249060B IT 1249060 B IT1249060 B IT 1249060B IT MI911439 A ITMI911439 A IT MI911439A IT MI911439 A ITMI911439 A IT MI911439A IT 1249060 B IT1249060 B IT 1249060B
Authority
IT
Italy
Prior art keywords
phlebostatic
ulcers
chronic
epitelization
cicatrization
Prior art date
Application number
ITMI911439A
Other languages
English (en)
Inventor
Doris Jacopo Bononi
Original Assignee
Bononi Ricerca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bononi Ricerca filed Critical Bononi Ricerca
Priority to ITMI911439A priority Critical patent/IT1249060B/it
Publication of ITMI911439A0 publication Critical patent/ITMI911439A0/it
Priority to EP92201340A priority patent/EP0514970A1/en
Priority to CA002069027A priority patent/CA2069027A1/en
Priority to JP4154231A priority patent/JPH05208915A/ja
Priority to KR1019920008816A priority patent/KR920021154A/ko
Publication of ITMI911439A1 publication Critical patent/ITMI911439A1/it
Application granted granted Critical
Publication of IT1249060B publication Critical patent/IT1249060B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

L'associazione di collagene ed eparan solfato quale principio attivo in una composizione per uso topico accelera la riepitelizzazione di ulcere flebostatiche croniche.
ITMI911439A 1991-05-24 1991-05-24 Composizione farmaceutica ad uso topico per il trattamento di cicatrizzazione e riepitelizzazione di ulcere flebostatiche croniche. IT1249060B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITMI911439A IT1249060B (it) 1991-05-24 1991-05-24 Composizione farmaceutica ad uso topico per il trattamento di cicatrizzazione e riepitelizzazione di ulcere flebostatiche croniche.
EP92201340A EP0514970A1 (en) 1991-05-24 1992-05-12 Pharmaceutical composition for topical use for the healing and reepithelization of chronic phlebostatic ulcers
CA002069027A CA2069027A1 (en) 1991-05-24 1992-05-20 Pharmaceutical composition for topical use for the healing and reepithelization of chronic phlebostatic ulcers
JP4154231A JPH05208915A (ja) 1991-05-24 1992-05-22 慢性の静脈静止性潰瘍の治療及び再上皮化に局所的に用いる製薬学的組成物
KR1019920008816A KR920021154A (ko) 1991-05-24 1992-05-25 만성 정맥혈울성 궤양의 치료와 상피재형성에 국부적으로 사용되는 제약학적 성분물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911439A IT1249060B (it) 1991-05-24 1991-05-24 Composizione farmaceutica ad uso topico per il trattamento di cicatrizzazione e riepitelizzazione di ulcere flebostatiche croniche.

Publications (3)

Publication Number Publication Date
ITMI911439A0 ITMI911439A0 (it) 1991-05-24
ITMI911439A1 ITMI911439A1 (it) 1992-11-24
IT1249060B true IT1249060B (it) 1995-02-11

Family

ID=11359986

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI911439A IT1249060B (it) 1991-05-24 1991-05-24 Composizione farmaceutica ad uso topico per il trattamento di cicatrizzazione e riepitelizzazione di ulcere flebostatiche croniche.

Country Status (5)

Country Link
EP (1) EP0514970A1 (it)
JP (1) JPH05208915A (it)
KR (1) KR920021154A (it)
CA (1) CA2069027A1 (it)
IT (1) IT1249060B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
SE9300139L (sv) * 1993-01-19 1994-07-20 Medicarb Ab Framställning av ett nytt läkemedel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6652M (it) * 1966-12-28 1969-01-27
US4808570A (en) * 1984-02-24 1989-02-28 University Of California Compositions and method for improving wound healing

Also Published As

Publication number Publication date
CA2069027A1 (en) 1992-11-25
ITMI911439A1 (it) 1992-11-24
ITMI911439A0 (it) 1991-05-24
EP0514970A1 (en) 1992-11-25
JPH05208915A (ja) 1993-08-20
KR920021154A (ko) 1992-12-18

Similar Documents

Publication Publication Date Title
ATE113650T1 (de) Ausgewählte stämme von lactobacillus enthaltende pharmazeutische zusammensetzungen.
NL300136I2 (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
FI951901L (fi) Stabiili pidennysti vapautuva, oraalisesti annosteltava koostumus
FI935929L (fi) Ny vaext regulerande faktor i stamcellen som foermaor foeroeka in vitro
FI952302L (fi) Pyran-2-onit ja 5,6-dihydropyranonit, jotka ovat käyttökelpoisia HIV:n ja muiden retrovirusten hoidossa
FI971536A0 (fi) Keratinosyytti-kasvutekijän analogeja
AU587307B2 (en) Verapamil dosage form
CA2031817A1 (en) Use of thrombospondin to promote wound healing
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
IT1252061B (it) Composizioni per uso dermatologico e cosmetico
IT1249060B (it) Composizione farmaceutica ad uso topico per il trattamento di cicatrizzazione e riepitelizzazione di ulcere flebostatiche croniche.
ATE104554T1 (de) Topische praeparate.
ITMI912466A0 (it) Uso di 1,2 dipalmitoil-l-alfa-fosfatidil-n-n-dimetiletanolammina in composizione dermatologiche
FR2652742B1 (fr) Compositions anallergiques cosmetiques et dermo-pharmaceutiques.
FI943875L (fi) 2,3,4,5-Tetrahydro-1H-3-bentsatsepiinejä ja niiden farmaseuttisesti hyväksyttäviä happoadditiosuoloja
IT8921023A0 (it) Derivati di fosfati della mitomicina con una attivita' antitumorale e una ridotta tossicita'.
AU3808493A (en) Biologically active N-acylprolyldipeptides having antiamnestic, antihypoxic and anorexigenic effects
KR900012400U (ko) 압축기의 베어링 구조
IT9048244A0 (it) Composizione farmaceutica ad effetto cicatrizzante.
FI903653A7 (fi) Paikallisesti annettava farmaseuttinen koostumus
ATA71491A (de) Pharmakologisch aktive in position 3 substituierte alpha-aminomethyl-2benzofuranmethanole
IT9048605A0 (it) Derivati della 1,2,3,4,-tetraidronaftilammina ad attivita' nootropica e composizioni farmaceutiche che li contengono.
IT9019970A0 (it) Composizioni farmaceutiche ad attivita' riduttrice di radicali ossigeno e loro preparazione
ITMI951252A0 (it) Bicarbonati di derivati della 2,6-dimetilanilina loro uso in terapia e composizioni farmaceutiche che li comprendono
IT8820740A0 (it) Derivati ad azione batteriostatica loro preparazione e composizioni farmaceutiche.

Legal Events

Date Code Title Description
0001 Granted